Vivo Capital as of March 31, 2019
Portfolio Holdings for Vivo Capital
Vivo Capital holds 49 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 24.0 | $241M | 2.0M | 117.70 | |
| Crinetics Pharmaceuticals In (CRNX) | 7.7 | $77M | 3.4M | 22.76 | |
| Codexis (CDXS) | 5.4 | $54M | 2.6M | 20.53 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.3 | $43M | 2.3M | 18.35 | |
| Kalvista Pharmaceuticals (KALV) | 3.9 | $39M | 1.4M | 28.62 | |
| Sinovac Biotech (SVA) | 3.8 | $38M | 5.9M | 6.47 | |
| Insmed (INSM) | 3.4 | $34M | 1.2M | 29.07 | |
| Kadmon Hldgs | 3.3 | $33M | 13M | 2.64 | |
| Homology Medicines | 3.2 | $32M | 1.2M | 27.73 | |
| Menlo Therapeutics | 3.1 | $32M | 4.0M | 7.85 | |
| Tricida | 2.9 | $30M | 781k | 37.80 | |
| Cymabay Therapeutics | 2.7 | $27M | 2.1M | 13.28 | |
| Biohaven Pharmaceutical Holding | 2.6 | $26M | 505k | 51.47 | |
| Eiger Biopharmaceuticals | 2.5 | $25M | 1.8M | 13.98 | |
| Mirati Therapeutics | 1.8 | $18M | 251k | 73.30 | |
| Mei Pharma | 1.8 | $18M | 5.8M | 3.07 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $15M | 1.6M | 9.51 | |
| Kiniksa Pharmaceuticals | 1.5 | $15M | 844k | 18.06 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $14M | 1.4M | 10.16 | |
| Acer Therapeutics | 1.4 | $14M | 579k | 24.30 | |
| Obseva Sa | 1.2 | $12M | 937k | 12.79 | |
| Amyris | 1.2 | $12M | 5.6M | 2.09 | |
| Uniqure Nv (QURE) | 1.1 | $11M | 180k | 59.65 | |
| Nabriva Therapeutics | 1.1 | $11M | 4.4M | 2.44 | |
| Zymeworks | 1.0 | $10M | 620k | 16.18 | |
| Aclaris Therapeutics (ACRS) | 1.0 | $9.9M | 1.6M | 5.99 | |
| Verona Pharma Plc ads (VRNA) | 1.0 | $9.7M | 1.5M | 6.50 | |
| Dermira | 0.9 | $9.5M | 700k | 13.55 | |
| Soleno Therapeutics | 0.9 | $9.0M | 4.4M | 2.06 | |
| Kala Pharmaceuticals | 0.9 | $8.6M | 1.0M | 8.27 | |
| Orchard Therapeutics Plc ads | 0.9 | $8.6M | 482k | 17.88 | |
| Galmed Pharmaceuticals | 0.8 | $7.9M | 971k | 8.17 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $7.9M | 1.2M | 6.50 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $7.5M | 384k | 19.50 | |
| Matinas Biopharma Holdings, In (MTNB) | 0.7 | $7.4M | 6.8M | 1.09 | |
| Zogenix | 0.6 | $5.8M | 105k | 55.01 | |
| Precision Biosciences Ord | 0.5 | $5.0M | 281k | 17.95 | |
| Genocea Biosciences | 0.5 | $4.6M | 7.8M | 0.59 | |
| Strongbridge Bioph shs usd | 0.5 | $4.6M | 914k | 4.98 | |
| Sierra Oncology | 0.4 | $4.2M | 2.4M | 1.71 | |
| Agile Therapeutics | 0.2 | $2.3M | 1.5M | 1.51 | |
| Dbv Technologies S A | 0.2 | $2.1M | 270k | 7.71 | |
| Zai Lab (ZLAB) | 0.2 | $2.1M | 72k | 29.51 | |
| Trevena | 0.2 | $1.9M | 1.2M | 1.56 | |
| Biopharmx | 0.1 | $1.5M | 16M | 0.09 | |
| Selecta Biosciences | 0.1 | $1.3M | 546k | 2.36 | |
| Akari Therapeutics | 0.1 | $1.2M | 346k | 3.58 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $121k | 99k | 1.22 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $28k | 189k | 0.15 |
